PMID- 35175572 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220409 IS - 2193-8210 (Print) IS - 2190-9172 (Electronic) VI - 12 IP - 3 DP - 2022 Mar TI - Effectiveness of Cimetidine as Adjuvant Therapy in the Treatment of Acute-Extrinsic Atopic Dermatitis: A Double-Blind Randomized Controlled Trial. PG - 715-726 LID - 10.1007/s13555-022-00688-z [doi] AB - INTRODUCTION: Acute extrinsic atopic dermatitis (AD) requires long-term treatment. Cimetidine could be used as an adjuvant therapy for acute-extrinsic AD due to immunomodulatory effects. This study aims to assess the effectiveness of cimetidine as an adjuvant to standard treatment in acute extrinsic AD. METHODS: This is a double-blind randomized controlled trial involving 26 AD patients aged 12-60 years from 2017 to 2020. Effectiveness of cimetidine was assessed by comparing SCORing Atopic Dermatitis (SCORAD) and objective SCORAD changes in both groups at week 2, 4, 6, and 8. Serum levels of immunoglobulin E (IgE), interferon (IFN)-gamma, interleukin (IL)-12, and IL-4 were also documented. RESULTS: Significant differences were observed in SCORAD changes at week 2, 4, 6, and 8 (p = 0.004; p = 0.001; p < 0.001; and p < 0.001 respectively), objective SCORAD changes at week 2, 4, 6, and 8 (p = 0.004, p = 0.001, p < 0.001, and p < 0.001 respectively), and IgE level changes at week 8 (p = 0.002) between the two groups. However, there were no significant changes in IFN-gamma, IL-12, and IL-4 levels between the two groups. CONCLUSION: Cimetidine is a safe and effective adjuvant therapy for acute-extrinsic AD. TRIAL REGISTRATION: NCT04018131. CI - (c) 2022. The Author(s). FAU - Novianto, Endi AU - Novianto E AUID- ORCID: 0000-0002-8688-4948 AD - Department of Dermatology and Venereology, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National Central General Hospital, 6 Salemba Raya, Central Jakarta, Jakarta, 10430, Indonesia. drendinovianto@gmail.com. FAU - Jacoeb, Tjut N A AU - Jacoeb TNA AD - Department of Dermatology and Venereology, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National Central General Hospital, 6 Salemba Raya, Central Jakarta, Jakarta, 10430, Indonesia. FAU - Indriatmi, Wresti AU - Indriatmi W AD - Department of Dermatology and Venereology, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National Central General Hospital, 6 Salemba Raya, Central Jakarta, Jakarta, 10430, Indonesia. FAU - Suhendro AU - Suhendro AD - Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National Central General Hospital, 6 Salemba Raya, Central Jakarta, Jakarta, 10430, Indonesia. FAU - Setiabudy, Rianto AU - Setiabudy R AD - Department of Pharmacology and Therapeutics, Faculty of Medicine Universitas Indonesia, 6 Salemba Raya, Central Jakarta, Jakarta, 10430, Indonesia. FAU - Setiabudy, Rahajuningsih D AU - Setiabudy RD AD - Department of Clinical Pathology, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National Central General Hospital, 6 Salemba Raya, Central Jakarta, Jakarta, 10430, Indonesia. FAU - Abdullah, Murdani AU - Abdullah M AD - Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National Central General Hospital, 6 Salemba Raya, Central Jakarta, Jakarta, 10430, Indonesia. FAU - Rengganis, Iris AU - Rengganis I AD - Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National Central General Hospital, 6 Salemba Raya, Central Jakarta, Jakarta, 10430, Indonesia. FAU - Suwarsa, Oki AU - Suwarsa O AD - Department of Dermatology and Venereology, Faculty of Medicine Universitas Padjajaran, Hasan Sadikin General Hospital, 38 Pasteur, Bandung, 40161, West Java, Indonesia. FAU - Soebaryo, Retno W AU - Soebaryo RW AD - Department of Dermatology and Venereology, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National Central General Hospital, 6 Salemba Raya, Central Jakarta, Jakarta, 10430, Indonesia. LA - eng SI - ClinicalTrials.gov/NCT04018131 PT - Journal Article DEP - 20220217 PL - Switzerland TA - Dermatol Ther (Heidelb) JT - Dermatology and therapy JID - 101590450 PMC - PMC8940995 OTO - NOTNLM OT - Atopic dermatitis OT - Cimetidine OT - Efficacy OT - IgE level OT - SCORAD EDAT- 2022/02/18 06:00 MHDA- 2022/02/18 06:01 PMCR- 2022/02/17 CRDT- 2022/02/17 12:28 PHST- 2021/12/14 00:00 [received] PHST- 2022/01/27 00:00 [accepted] PHST- 2022/02/18 06:00 [pubmed] PHST- 2022/02/18 06:01 [medline] PHST- 2022/02/17 12:28 [entrez] PHST- 2022/02/17 00:00 [pmc-release] AID - 10.1007/s13555-022-00688-z [pii] AID - 688 [pii] AID - 10.1007/s13555-022-00688-z [doi] PST - ppublish SO - Dermatol Ther (Heidelb). 2022 Mar;12(3):715-726. doi: 10.1007/s13555-022-00688-z. Epub 2022 Feb 17.